uring the past couple of years several authors reported on favourable effects of deep neuromuscular block (NMB) during laparoscopic surgery, suggesting that deep NMB provides suitable surgical space at a reduced inflation pressure, which in turn decreases postoperative pain perception and finally improves outcome of surgery. No matter how promising this suggestion would appaer, the issue is still open to be debated (1).
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What we know about this topic is that the inflation of the abdominal cavity may result in hemodynamic changes and that early postoperative pain increases along with incrementally augmented pressure (2) . We know that low intraabdominal pressure may compromise the visibility in surgical space and thus may increase the risk of conversion to laparotomy.
To get clear indications for the use of deep NMB during laparoscopic procedures, the following questions have to be answsered.
Firstly, is low inflation pressure is really necessary for laparoscopic surgeries? A Cochrane review compared the effect of low (12 mmHg) and standard (16 mmHg) pressure pneumoperitoneum on the outcome of laparoscopic cholecystectomies. No difference was found between the two groups in surgical morbidity, in conversion rate to open surgery and in patient satisfaction (3) . The haemodynamic differences were insignificant and may also have been attributed to differences in inflation techniques or in patients' positioning. Thus low pressure pneumoperitoneum does not appear to offer significant advantage.
Secondly, is their a close correlation between surgical space conditions and surgeons' satisfaction? Surly every anaestitists experienced the typical bad mood of surgeons about poor surgical space conditions like "the patient is pressing, I cannot see properly" sometimes justified, but more often not, irrespective of the depth of NMB. Although several investigators reported batter rating score by surgeons when deep NMB was administred, the quality of data leaves something to be desired (e.g.better assessor blinding, less subjectivity). The third question is whether objective neuromuscular monitoring is a must during laparoscopic surgery? Actually, the majority of anesthetist rely on clinical evaluation of the relaxant effect instead of objective monitoring (9) . Under these circumstances the wide use of deep NMB increses the risk of postoperative muscle paralysis, thus cannot be recommended. Kotake et al. (10) assessed patients who recieved sugammadex for reversal before extubation of the trachea based on clinical signs of residual paralysis. They found that in 4.3% of patients the reversal of the block was insufficient (TOFR <0.9). Recently Nemes et al. (11) demonstrated that pharmacological reversal based on clinical signs of muscle paralysis was superior to spontaneous recovery, but it did not preclude postoperative residual block, irrespective of the reversal agent. Therefore, we recommend the routine use of objective neuromuscular monitoring during laparoscopic surgery in order to verify the depth of block as well as adequate recovery. This is in line with a recently published international Consensus Statment about the use of neuromuscular monitors (12).
Last but not least the costs generated by using deep NMB should also be taken into account. When intermediate acting relaxants are given, deep block is maintained by administration of repeated boli or IV infusion creating cost increase. The recommended dose of sugammadex is minimum 4 mg kg -1 for the reversal of a deep rocuronium or vecuronium induced block. Accordingly, 2 vials of 200 mg sugammadex must be opened for avarege patients weighing 70 or 80 kg; this doubles the cost of reversal versus moderate block. However, if pipecuronium is used instead of rocuronium to elicit deep NMB and sugammadex 2 mg kg -1 for reversal, costs can be reduced to the half. Pipecuronium is a steroidal neuromuscular blocker with long duration of action. Its use was discontinued in the 1990s due to its long duration of action being afraid of postoperative residual blockade. Nevertheless, pipecuronium is an excellent, potent NMB agent without side effects and histamine release does not appear to be a problem. With the emergence of sugammadex it turned out that this new reversal agent has high affinity for pipecuronium. A recent clinical study proved that sugammadex 2 mg kg -1 promptely and safely reverses deep NMB from pipecuronium (13) . Therefore, the combination of pipecuronium block with sugammadex reversal can be regarded a new paradigm for deep NMB.
In summary, there is no convincing evidence for the routine use of deep NMB during laparoscopic surgery. Further studies specifically designed and based on appropriate electrophysiological measurements are needed to prove the benefit of deep NMB during laparoscopic surgery.
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